United States · FDA National Drug Code directory

SODIUM PHENYLACETATE AND SODIUM BENZOATE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 70511-101_c158c088-1ab5-4099-a174-96aba96feb11
Product NDC: 70511-101
Form: INJECTION, SOLUTION, CONCENTRATE
Composition / generic term: sodium phenylacetate and sodium benzoate
Labeler: MAIA PHARMACEUTICALS, INC
Marketing category: ANDA
Marketing start / end (source format): 20170522
Source listing expiry: 20261231

Source-listed ingredients

SODIUM PHENYLACETATE — 100 mg/mL
SODIUM BENZOATE — 100 mg/mL

These values do not establish equivalence or a dose recommendation.

Packages

1 VIAL, SINGLE-DOSE in 1 CARTON (70511-101-50) / 50 mL in 1 VIAL, SINGLE-DOSE · 70511-101-50

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →